Table 2 Comparison of in vitro uptake of 18F-FDG between LoVo and HT29 cells (%).

From: Noninvasive evaluation of 18F-FDG/18F-FMISO-based Micro PET in monitoring hepatic metastasis of colorectal cancer

 

LoVo

HT29

P

30 min

12.24 ± 1.69

6.15 ± 0.075

0.003

60 min

22.49 ± 1.072

11.96 ± 0.2

0.003

120 min

24.71 ± 3.8

21.85 ± 1.178

0.282

240 min

31.7 ± 1.509

26.36 ± 2.218

0.026

  1. RMANOVA (time*groups), P = 0.000; t test (LoVo vs. HT29): P = 0.003, 0.003, 0.026 at 30, 60, 240 min, respectively.
Back to article page